In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

70. If the last few months are any guide, there will be no shortage of surprises and challenges for the biotech industry in the new year. Donald Trump will begin his second term, possibly bringing ...

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

Three biotech VC veterans ... Scion was started by former Apple Tree Partners colleagues Sam Hall and Aaron Kantoff, along with Tadd Wessel, managing partner of the health care private equity ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

The biotech industry’s DeepSeek moment came last fall. That is when Summit Therapeutics, backed by billionaire Bob Duggan, ...

The macroenvironment in 2025 looks grim as signs of a slowdown in the economy set in. The biotech industry experienced a choppy ride in 2024, and the same is likely in store in 2025. Given the ...

The Biotech industry has underperformed due to the Trump administration, RFK Jr.'s skepticism, and funding uncertainty, with major ETFs down 19-25% over six months. Some biotech companies with ...